Anticholinergic side-effects of drugs in elderly people

Salom IL , Davis K. Prescribing for older patients: how to avoid toxic drug reactions. Geriatrics 1995; 50: 37–40

Royal College of Physicians. Medication for Elderly People. London: RCP, 1997

Furniss L , Burns A , Craig S , Cooke J , Scobie S. The effect of a pharmacist's intervention in nursing and residential homes. Br J Psychiatry (in press)

Blazer DG , Federspiel CF , Ray WA , Schaffner W. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol 1983; 38: 31–5

Peters NL. Snipping the thread of life. Antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989; 149: 2414–20

Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993; 3: 335–48

Tune L , Carr S , Hoag E , Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992; 149: 1393–4

Martindale the Extra Pharmacopeia. London: Pharmaceutical Press, 1989

Williamson J , Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980; 9: 73–9

OTA Project Staff, Solan G , Behney C Prescription Drugs and Elderly Americans: Ambulatory Use and Approaches for Coverage for Medicare. Washington, DC: US Congress Office of Technology Assessment, Health Program, 1987

Jitapunkal S , Pillay I , Ebrahim S. Delirium in newly admitted elderly persons: a prospective study. Quart J Med 1992; 83: 307–14

Rovner BW , Edelman BA , Cox MP The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992; 149: 1390–2

Lasser RA , Sunderland T. Neuropsychotropic medication use in nursing home residents. J Am Geriatr Soc 1998; 46: 202–7

Seifert R , Jamieson J , Gardner R. Use of anticholinergics in the nursing home: an empirical study. Drug Intell Clin Pharmacy 1983; 17: 470–3

Spore D , Mor V , Larrat EP , Hiris J , Hawes C. Regulatory environment and psychotropic use in board-and-care facilities: results of a 10-state study. J Geront A Biol Sci Med Sci 1996; 51: M131–41

Gerson SC , Plotkin DA , Jarvik LF. Antidepressant drug studies 1964 to 1986: empirical evidence for aging patients. J Clin Psychopharmacol 1998; 8: 311–22

Alexopoulos GS. Treatment of depression. In: Salzman C , ed. Clinical Geriatric Psychopharmacology Baltimore: Williams & Wilkins, 1992

Meyers BS , Kalayam B. Update in geriatric psychopharmacology. In: Billig N , Rabind PV , eds. Issues in Geriatric Psychiatry. Basel: Karger, 1989: 114–37

Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993; 94: 2S–12S

Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 1993; 54: 23–8

Katona CLE. New antidepressants in the elderly. In: Holmes C Howard R , eds. Advances in Old Age Psychiatry: Chromosomes to Community Care. Petersfield: Wrightson Biomedical Publishing, 1997; 143–60

Katona C , Livingston G , Manela M The symptomatology of depression in the elderly. Int J Psychopharmacol 1997; 12(suppl 7):S19–23

Yeager BF , Farnett LE , Ruzicka SA. Management of the behavioral manifestations of dementia. Arch Intern Med 1995; 155: 250–60

Sunderland T. Treatment of the elderly suffering from psychosis and dementia. J Clin Psychiatry 1996; 57(suppl 9):53–6

Herrmann N , Lanctot KL , Naranjo CA. Behavioral disorders in demented elderly patients: current issues in pharmacotherapy. CNS Drugs 1996; 6: 2180–300

Stoppe G , Brandt CA , Staedt JH. Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs Aging 1999; 14: 41–54

Bolden C , Cusack B , Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 1992; 260: 576–80

Bymaster FP , Calligaro MS , Falcone JF Radioceptor binding profile of the atypical antipsychotic olazapine. Neuropsychopharmacology 1996; 14: 87–96

Goff DC , Schader RI. Non-neurological side effects of antipsychotic agents. In: Hirsch SR , Weinberger DR , eds. Schizophrenia. Oxford: Blackwell Science, 1995: 566–84

Katz IR , Jeste DV , Mintzer JE , Clyde C , Napolitano J , Brecher M. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999; 60: 107–15

De Deyn PP , Rabberu K , Ramussen A A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999; 53: 946–55

Kumar V. Use of atypical antidepressants in geriatric patients: a review. Int J Geriatr Psychopharmacol 1997; 1: 15–23

Pitner JK , Mintzer JE , Pennypacker LC , Jackson CW. Efficacy and adverse effects of clozapine in four elderly psychotic patients. J Clin Psychiatry 1995; 56: 180–5

Chengappa KN , Baker RW , Kreinbrook SB , Adair D. Clozapine use in female geriatric patients with psychoses. J Geriatr Psychiatr Neurol 1995; 8: 12–5

Staedt J , Stoppe G , Hajak G , Ruther E. Rebound insomnia after abrupt clozapine withdrawal. Eur Arch Psychiatry Clin Neurosci 1996; 246: 79–82

Durst R , Teitelbaum A , Katz G , Knobler HY. Withdrawal from clozapine: the “rebound phenomenon”. Isr J Psychiatry Relat Sci 1999; 36: 122–8

Ahmed S , Chengappa KN , Naidu VR , Baker RW , Parepally H , Schooler NR. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry 1998; 59: 472–7

Borison RL. Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing. Clin Ther 1996; 18: 592–607

Ettinger RL. Xerostomia: a complication of ageing. Aust Dent J 1981; 1: 111–16

Baker KA , Ettinger RL. Intra-oral effects of drugs in elderly persons. Geridontics 1985; 1: 111–16